Giuseppe
Emeritus
[Source: Eurosurveillance, full page: (LINK). Abstract, edited.]
S Caini (
)<SUP>1</SUP><SUP>,2</SUP>, A Hajdu<SUP>1</SUP>, A Kurcz<SUP>1</SUP>, K B?r?cz<SUP>1</SUP>
Citation style for this article: Caini S, Hajdu A, Kurcz A, B?r?cz K. Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005-2010. Euro Surveill. 2013;18(2)
ii=20352. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20352
Date of submission: 18 March 2012 <HR>Healthcare-associated infections caused by multidrug-resistant organisms are associated with prolonged medical care, worse outcome and costly therapies. In Hungary, hospital-acquired infections (HAIs) due to epidemiologically important multidrug-resistant organisms are notifiable by law since 2004. Overall, 6,845 case-patients (59.8% men; median age: 65 years) were notified in Hungary from 2005 to 2010. One third of case-patients died in hospital. The overall incidence of infections increased from 5.4 in 2005 to 14.7 per 100,000 patient-days in 2010. Meticillin-resistant Staphylococcus aureus (MRSA) was the most frequently reported pathogen (52.2%), but while its incidence seemed to stabilise after 2007, notifications of multidrug-resistant Gram-negative organisms have significantly increased from 2005 to 2010. Surgical wound and bloodstream were the most frequently reported sites of infection. Although MRSA incidence has seemingly reached a plateau in recent years, actions aiming at reducing the burden of HAIs with special focus on Gram-negative multidrug-resistant organisms are needed in Hungary. Continuing promotion of antimicrobial stewardship, infection control methodologies, reinforced HAI surveillance among healthcare and infection control practitioners, and engagement of stakeholders, hospital managers and public health authorities to facilitate the implementation of existing guidelines and protocols are essential.
- -----
Eurosurveillance, Volume 18, Issue 2, 10 January 2013
Surveillance and outbreak reports
Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005-2010
Surveillance and outbreak reports
Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005-2010
S Caini (
- National Center for Epidemiology (NCE), Budapest, Hungary
- European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Citation style for this article: Caini S, Hajdu A, Kurcz A, B?r?cz K. Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005-2010. Euro Surveill. 2013;18(2)
ii=20352. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20352 Date of submission: 18 March 2012 <HR>Healthcare-associated infections caused by multidrug-resistant organisms are associated with prolonged medical care, worse outcome and costly therapies. In Hungary, hospital-acquired infections (HAIs) due to epidemiologically important multidrug-resistant organisms are notifiable by law since 2004. Overall, 6,845 case-patients (59.8% men; median age: 65 years) were notified in Hungary from 2005 to 2010. One third of case-patients died in hospital. The overall incidence of infections increased from 5.4 in 2005 to 14.7 per 100,000 patient-days in 2010. Meticillin-resistant Staphylococcus aureus (MRSA) was the most frequently reported pathogen (52.2%), but while its incidence seemed to stabilise after 2007, notifications of multidrug-resistant Gram-negative organisms have significantly increased from 2005 to 2010. Surgical wound and bloodstream were the most frequently reported sites of infection. Although MRSA incidence has seemingly reached a plateau in recent years, actions aiming at reducing the burden of HAIs with special focus on Gram-negative multidrug-resistant organisms are needed in Hungary. Continuing promotion of antimicrobial stewardship, infection control methodologies, reinforced HAI surveillance among healthcare and infection control practitioners, and engagement of stakeholders, hospital managers and public health authorities to facilitate the implementation of existing guidelines and protocols are essential.